270 related articles for article (PubMed ID: 26346170)
1. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules.
Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S
Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170
[TBL] [Abstract][Full Text] [Related]
2. Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts.
Lee NP; Chan KT; Choi MY; Lam HY; Tung LN; Tzang FC; Han H; Lam IP; Kwok SY; Lau SH; Man C; Tong DK; Wong BL; Law S
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1199-207. PubMed ID: 26553104
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
4. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
Qin X; Qiu F; Zou Z
Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
[TBL] [Abstract][Full Text] [Related]
5. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
Chen C; Ma Z; Zhang H; Liu X; Yu Z
Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
[TBL] [Abstract][Full Text] [Related]
8. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.
Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma.
Qi YJ; Wang M; Liu RM; Wei H; Chao WX; Zhang T; Lou Q; Li XM; Ma J; Zhu H; Yang ZH; Liu HQ; Ma YF
PLoS One; 2014; 9(4):e95386. PubMed ID: 24743601
[TBL] [Abstract][Full Text] [Related]
11. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
Liu X; Ma W; Yan Y; Wu S
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP.
Wen J; Zheng B; Hu Y; Zhang X; Yang H; Li Y; Zhang CY; Luo KJ; Zang X; Li YF; Guan XY; Fu JH
Int J Oncol; 2010 Jan; 36(1):265-74. PubMed ID: 19956855
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma.
Hui MK; Lai KK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
Med Oncol; 2012 Dec; 29(5):3009-16. PubMed ID: 22528514
[TBL] [Abstract][Full Text] [Related]
14. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.
Kuo IY; Huang YL; Lin CY; Lin CH; Chang WL; Lai WW; Wang YC
J Biomed Sci; 2019 Feb; 26(1):20. PubMed ID: 30777052
[TBL] [Abstract][Full Text] [Related]
15. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
16. Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.
Rafiq R; Bhat GA; Lone MM; Masood A; Dar NA
Tumour Biol; 2016 Aug; 37(8):10193-207. PubMed ID: 26831662
[TBL] [Abstract][Full Text] [Related]
17. Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1.
Ge R; Liu L; Dai W; Zhang W; Yang Y; Wang H; Shi Q; Guo S; Yi X; Wang G; Gao T; Luan Q; Li C
J Invest Dermatol; 2016 Jun; 136(6):1219-1228. PubMed ID: 26880244
[TBL] [Abstract][Full Text] [Related]
18. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.
Zhang J; Yang X; Wang Y; Shi H; Guan C; Yao L; Huang X; Ding Z; Huang Y; Wang H; Cheng C
Dig Dis Sci; 2013 Jul; 58(7):2028-37. PubMed ID: 23456497
[TBL] [Abstract][Full Text] [Related]
19. Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells.
Gao D; Hu J; Zhang X; Gao C; Hong J
Cancer Biother Radiopharm; 2013; 28(6):433-40. PubMed ID: 23806019
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.
Chen Y; Li Z; Dong Z; Beebe J; Yang K; Fu L; Zhang JT
Mol Cancer Res; 2017 Apr; 15(4):418-428. PubMed ID: 28087741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
